NO990322L - Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist - Google Patents

Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist

Info

Publication number
NO990322L
NO990322L NO990322A NO990322A NO990322L NO 990322 L NO990322 L NO 990322L NO 990322 A NO990322 A NO 990322A NO 990322 A NO990322 A NO 990322A NO 990322 L NO990322 L NO 990322L
Authority
NO
Norway
Prior art keywords
antagonist
5ht2c
mixture containing
pharmaceutical mixture
compounds
Prior art date
Application number
NO990322A
Other languages
Norwegian (no)
Other versions
NO990322D0 (en
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990322D0 publication Critical patent/NO990322D0/en
Publication of NO990322L publication Critical patent/NO990322L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

Det beskrives kombinasjoner av forbindelser som har 5HT2C- og D2-antagonistvirkning, forbindelser som har aktivitet ved de to reseptorene, farmasøytiske blandinger hvori disse inngår, og deres anvendelse ved behandling av schizofreni.Combinations of compounds having 5HT2C and D2 antagonist activity are described, compounds having activity at the two receptors, pharmaceutical compositions comprising them, and their use in the treatment of schizophrenia.

NO990322A 1996-07-26 1999-01-25 Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist NO990322L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (2)

Publication Number Publication Date
NO990322D0 NO990322D0 (en) 1999-01-25
NO990322L true NO990322L (en) 1999-03-24

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990322A NO990322L (en) 1996-07-26 1999-01-25 Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist

Country Status (19)

Country Link
EP (1) EP0936924A2 (en)
JP (1) JP2000516924A (en)
KR (1) KR20000029564A (en)
CN (1) CN1230894A (en)
AR (1) AR008083A1 (en)
AU (1) AU725817B2 (en)
BR (1) BR9710568A (en)
CA (1) CA2261813A1 (en)
CO (1) CO5031292A1 (en)
CZ (1) CZ23799A3 (en)
GB (1) GB9615767D0 (en)
HU (1) HUP9903619A3 (en)
IL (1) IL128219A0 (en)
NO (1) NO990322L (en)
NZ (1) NZ333813A (en)
PL (1) PL331426A1 (en)
TR (1) TR199900140T2 (en)
WO (1) WO1998004289A2 (en)
ZA (1) ZA976593B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
ES2237188T3 (en) 1998-11-23 2005-07-16 Sepracor Inc. DEMETILOLANZAPINE COMPOSITIONS AND METHODS.
WO2000030648A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
ATE253364T1 (en) * 1998-11-23 2003-11-15 Sepracor Inc PHARMACEUTICAL COMPOSITIONS CONTAINING OLANZAPINE-N-OXIDES
EP1165090A2 (en) 1999-03-18 2002-01-02 Children's Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
WO2000071106A2 (en) * 1999-05-19 2000-11-30 Astrazeneca Ab Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (en) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
AU4297297A (en) 1998-02-20
CO5031292A1 (en) 2001-04-27
BR9710568A (en) 1999-08-17
WO1998004289A2 (en) 1998-02-05
AU725817B2 (en) 2000-10-19
HUP9903619A2 (en) 2000-10-28
PL331426A1 (en) 1999-07-19
NZ333813A (en) 2000-07-28
HUP9903619A3 (en) 2001-03-28
NO990322D0 (en) 1999-01-25
GB9615767D0 (en) 1996-09-04
KR20000029564A (en) 2000-05-25
ZA976593B (en) 1999-01-25
IL128219A0 (en) 1999-11-30
CN1230894A (en) 1999-10-06
JP2000516924A (en) 2000-12-19
CZ23799A3 (en) 1999-06-16
CA2261813A1 (en) 1998-02-05
AR008083A1 (en) 1999-12-09
TR199900140T2 (en) 1999-03-22
WO1998004289A3 (en) 1998-03-19
EP0936924A2 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
TR200101859T2 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
EE200000320A (en) Novel compounds
BR0108678A (en) New compounds
NO963506D0 (en) 4-Heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents
SE9504661D0 (en) New compounds
AU5624699A (en) Use of 5ht-6 antagonists
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
ATE302606T1 (en) N-UREIDOALKYLPIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
SE9704546D0 (en) Novel compounds
DK1097173T3 (en) Use of IL-2 peptides and derivatives thereof as therapeutic agents
NO984290L (en) Pharmaceutically useful compounds
NO990322L (en) Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist
PT1024809E (en) UTILIZATION OF IMMUNOMODULATION AGENTS
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
BR9705456A (en) Heterocyclic compounds, aminomethyl process for their preparation and pharmaceutical compositions that contain them.
SE9504662D0 (en) New compounds
NO992298L (en) Conformationally limited LH-RH analogs, their use and pharmaceutical compositions containing these
DK0763535T3 (en) Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as central nervous system active compounds
AU580890B2 (en) P-acylaminobenzamides
BR9606955A (en) Substituted heterocycloalkenes
BR9812002A (en) Compounds with anti-first pass effect
NO952483D0 (en) Sesquiterpenes, their preparation and use as inhibitors affecting gababenzodiazepine receptors
SE9803277D0 (en) Novel compounds
ATE268768T1 (en) ANTITHROMBOTIC AGENTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application